Aug 2026· Advancement of science· 0 citations· 45 references
Medicine
TL;DR
This work establishes macrophage RSAD2 as a central hub that coordinates two mtDNA‐dependent inflammatory axes, revealing a feedforward immuno‐metabolic circuit with broad implications for inflammation‐driven diseases.
Abstract
ABSTRACT It is well established that mitochondrial DNA (mtDNA) synthesis governs macrophage function, yet its role in tissue repair and inflammation remains poorly understood. Using a mouse skin injury model combined with spatial transcriptomics and functional assays, we identify radical s‐adenosyl methionine domain containing 2 (RSAD2) as a critical regulator of mtDNA‐driven inflammation in macrophages. Mechanistically, RSAD2 directly binds the N‐terminal domain of cytidylate monophosphate kinase 2 (CMPK2), a rate‐limiting enzyme for mtDNA synthesis, and dually modulates its activity: it inhibits K63‐linked ubiquitination to stabilize CMPK2, and recruits casein kinase 2 alpha 2 (Csnk2a2) to promote CMPK2 phosphorylation, thereby enhancing mtDNA production. Newly synthesized mtDNA amplifies inflammation through two coordinated pathways: activation of a cGAS‐STING‐IRF3‐RSAD2 feedforward loop, and synergistic activation of the NLR family pyrin domain containing 3 (NLRP3) inflammasome. These pathways orchestrate inflammatory amplification in macrophages to modulate skin repair. Our work establishes macrophage RSAD2 as a central hub that coordinates two mtDNA‐dependent inflammatory axes, revealing a feedforward immuno‐metabolic circuit with broad implications for inflammation‐driven diseases.
Mitochondrial DNA (mtDNA) is increasingly recognized as a damage-associated molecular pattern (DAMP) that signals mitochondrial injury and the consequent prodeath molecular signature. Such mtDNA release triggers programmed necrotic pathways, specifically necroptosis and pyroptosis, both of which are central to the path...
Andrea Marciníková, I. Jarabicová, C. Horváth et al.· American Journal of Physiolo...· 0 citations
Neurodegenerative diseases (NDDs) are commonly accompanied by persistent low-grade neuroinflammation, yet current therapies rarely achieve durable disease modification. This review aims to systematically delineate the role of mitochondrial DNA (mtDNA) leakage in linking mitochondrial injury to innate immune activation...
Hui Liu, Yao Zhang, Zi-Liang Zhuo et al.· Experimental and Therapeutic...· 0 citations
Abnormal release of mitochondrial DNA (mtDNA) and innate immune sensing play key roles in tumor immune regulation, but how they work together with ferroptosis is still unclear. This study aims to clarify the molecular mechanism of how mtDNA reshapes the tumor immune microenvironment in coordination with ferroptosis thr...
Gang Liu, Jia Wang, Li-Qiang An· Global Health Care· 1 citation
ABSTRACT Sarcopenia in chronic obstructive pulmonary disease (COPD) is driven by elevated tumor necrosis factor‐alpha (TNF‐α), yet the underlying mechanism remains unclear. Here, we identify the mitochondrial metabolic enzyme Prodh2 as a pivotal mediator. Prodh2 was significantly upregulated in sarcopenic COPD patients...
Gang Chen, Zhi-Tao Shangguan, Jing-Jing Gong et al.· Aging Cell· 0 citations
This work integrates transcriptomics with whole-cell and purified mitochondrial proteomics to profile lipopolysaccharide (LPS)/interferon-γ (IFN-γ)– and interleukin-4 (IL-4)/IL-13–stimulated macrophages and identifies mtDNA expression, intramitochondrial translation, and mitochondrial membrane potential as critical, dr...
Joan Blanco-Fernández, Miriam Lisci, Mads M. Foged et al.· Science Advances· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.